HomePSTTF โข OTCMKTS
add
Prescient Therapeutics Ltd
Sakop ng taon
$0.14 - $0.14
Market cap
69.93M AUD
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.55M | 75.34% |
Gastos sa pagpapatakbo | 4.02M | 61.47% |
Net na kita | -2.44M | -5.52% |
Net profit margin | -156.80 | 39.82% |
Kita sa bawat share | โ | โ |
EBITDA | -2.46M | -53.80% |
Aktuwal na % ng binabayarang buwis | โ | โ |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.93M | -52.27% |
Kabuuang asset | 14.56M | -28.59% |
Kabuuang sagutin | 3.17M | 36.50% |
Kabuuang equity | 11.39M | โ |
Natitirang share | 805.32M | โ |
Presyo para makapag-book | โ | โ |
Return on assets | -42.27% | โ |
Return on capital | -54.05% | โ |
Cash Flow
Net change in cash
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.44M | -5.52% |
Cash mula sa mga operasyon | -727.11K | 62.84% |
Cash mula sa pag-invest | 1.00M | -75.00% |
Cash mula sa financing | -17.14K | โ |
Net change in cash | 260.74K | -87.20% |
Malayang cash flow | -1.38M | -43.48% |
Tungkol
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
Itinatag
May 22, 1986
Website
Mga Empleyado
3
